RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 712-719

  Fyrberg, Anna ^a   Albertioni, Freidoun ^b   Lotfi, Kourosh ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Deoxycytidine kinase; Deoxyguanosine kinase; Nucleoside analogue; Resistance; RNA interference

Indexed keywords

CDA; CLOFARABINE; CYTARABINE; DEOXYCYTIDINE; DEOXYGUANOSINE KINASE; FARAA; GEMCITABINE; GUANINE ARABINOSIDE; MESSENGER RNA; NUCLEOSIDE ANALOG; SMALL INTERFERING RNA; TETRAZOLIUM;

CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY TEST; DEPLETION; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; RNA INTERFERENCE;

CELL LINE, TUMOR; DEOXYCYTIDINE KINASE; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NUCLEOSIDES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 46749123028     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802145231     Document Type: Conference Paper

References (23)

1. Lotfi, K.; Mansson, E.; Peterson, C.; Eriksson, S.; Albertioni, F. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. Biochem. Biophys. Res. Commun. 2002, 293, 1489-1496.
2. Bai, L.; Yamaguchi, M.; Tatsumi, M.; Kon, K.; Brautigam, M. Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-D-arabinofuranosyl-2-fluoroadenine. J. Cancer Res. Clin. Oncol. 1998, 124, 367-373.
3. Lotfi, K. ;Mansson, E.; Spasokoukotskaja, T.; Pettersson, B.; Liliemark, J.; et al., Biochemical pharmacology and resistance to 2-chloro-2′- arabino-fluoro-2′-deoxyadenosine, a novel analogue of cladribine in human leukemic cells. Clin. Cancer Res. 1999, 5, 2438-2444.
4. Leoni, L.M.; Chao, Q.; Cottam, H.B.; Genini, D.; Rosenbach, M.; et al. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′- deoxyadenosine 5′-triphosphate and cytochrome c. Proc. Natl. Acad. Sci. USA 1998, 95, 9567-9571.
5. Lotfi, K.; Mansson, E.; Chandra, J.; Wang, Y.; Xu, D.; et al. Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide. Br. J. Haematol. 2001, 113, 339-346.
6. Lofgren, C.; Hjortsberg, L.; Blennow, M.; Lotfi, K.; Paul, C.; et al. Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. Biochem. Biophys. Res. Comm. 2004, 320, 825-832.
7. Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001, 411, 494-498.
8. Mansson, E.; Liliemark, E.; Soderhall, S.; Gustafsson, G.; Eriksson, S.; Albertioni, F. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia. Leukemia. 2002, 16, 386-392.
9. Fyrberg, A.; Albertioni, F.; Lotfi, K. Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes. Biochem. Biophys. Res. Comm. 2007, 357, 847-853.
10. Lowry, O.H.; Rosebrough, N.J.; Farr, AL.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
11. Beausejour, C.M.; Tremblay, G.; Momparler, R.L. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs. Biochem. Biophys. Res. Comm. 2000, 278, 569-575.
12. Lotfi, K.; Karlsson, K.; Fyrberg, A.; Juliusson, G.; Jonsson, V.; et al. The pattern of deoxycytidineand deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. Biochem. Pharmacol. 2006, 71, 882-890.
13. Lotfi, K.; Zackrisson, A.L.; Peterson, C. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance. Cancer Lett. 2002,178, 141-149.
14. Johansson, M.; Karlsson, A. Cloning and expression of human deoxyguanosine kinase cDNA. Proc. Natl. Acad. Sci. USA 1996, 93, 7258-7262.
15. Wang, L.; Karlsson, A.; Arner, E.S.; Eriksson, S. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J. Biol. Chem. 1993, 268, 22847-22852.
16. Zhu, C.; Johansson, M.; Permert, J.; Karlsson, A. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines. J. Biol. Chem. 1998, 273, 14707-14711.
17. Zhu, C.; Johansson, M.; Karlsson, A. Differential incorporation of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosylguanine into nuclear and mitochondrial DNA. FEBS Lett. 2000,474, 129-132.
18. Hapke, D.M.; Stegmann, A.P.; Mitchell, B.S. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity. Cancer Res. 1996, 56, 2343-2347.
19. Sjoberg, A.H.; Wang, L.; Eriksson, S. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. Mol. Pharmacol. 1998, 53, 270-273.
20. Mansson, E.; Flordal, E.; Liliemark, J.; Spasokoukotskaja, T.; Elford, H.; et al. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. Biochem. Pharmacol. 2003, 65, 237-247.
21. van de Wiel, M.A.; Costa, J.L.; Smid, K.; Oudejans, C.B.; Bergman, A.M.; et al. Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations. Cancer Res. 2005, 65, 10208-10213.
22. Bierau, J.; van Gennip, A.H.; Leen, R.; Meinsma, R.; Caron, H.N.; van, Kuilenburg, A.B. Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma. Cancer Chemother. Pharmacol. 2005, 1-9.
23. Jordheim, L.P.; Cros, E.; Gouy, M.H.; Galmarini, C.M.; Peyrottes, S.; Mackey, J.; et al. Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. Clin. Cancer Res. 2004, 10, 5614-5621.